Jianping Wang
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- Colorectal Cancer Surgical Treatments
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 63
- Colorectal Cancer Surgical Treatments 28
- Peptidase Inhibition and Analysis 10
- Colorectal Cancer Treatments and Studies 9
-
- Protein Degradation and Inhibitors 5
- Co-authors
- Sagar Lonial (14 shared papers)Ajai Chari (8 shared papers)Brendan M. Weiss (10 shared papers)Yanhong Deng (20 shared papers)Jun Hu (3 shared papers)Tahamtan Ahmadi (6 shared papers)Lei Wang (11 shared papers)Lekun Fang (4 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Blood (10 papers)Oncotarget (4 papers)Diseases of the Colon & Rectum (4 papers)Medical Oncology (4 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Jianping Wang
149 papers receiving 3.6k citations
Jianping Wang's Hit Papers
Peers
Comparison fields: 5 of 122
- Hematology 906
- Oncology 1.6k
- Cancer Research 429
- Molecular Biology 1.3k
- Genetics 161
Countries citing papers authored by Jianping Wang
This map shows the geographic impact of Jianping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Wang more than expected).
Fields of papers citing papers by Jianping Wang
This network shows the impact of papers produced by Jianping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Wang. The network helps show where Jianping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 318 | |
| 2 | Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma Hit paper breakdown → | 2016 | 310 |
| 3 | 2013 | 232 | |
| 4 | 2014 | 193 | |
| 5 | 2014 | 151 | |
| 6 | 2016 | 109 | |
| 7 | 2019 | 101 | |
| 8 | 2015 | 94 | |
| 9 | 2013 | 87 | |
| 10 | 2018 | 86 | |
| 11 | 2020 | 76 | |
| 12 | 2013 | 74 | |
| 13 | 2017 | 62 | |
| 14 | 2015 | 62 | |
| 15 | 2013 | 59 | |
| 16 | 2011 | 57 | |
| 17 | 2002 | 55 | |
| 18 | 2011 | 45 | |
| 19 | 2014 | 43 | |
| 20 | 2015 | 43 |
About Jianping Wang
Jianping Wang is a scholar working on Oncology, Molecular Biology, Hematology, Surgery and Pathology and Forensic Medicine, having authored 156 papers that have together received 3.6k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (28 papers), Multiple Myeloma Research and Treatments (22 papers), Peptidase Inhibition and Analysis (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Colorectal and Anal Carcinomas (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Hematology (906 citations), Oncology (1.6k citations), Cancer Research (429 citations), Molecular Biology (1.3k citations) and Genetics (161 citations). Jianping Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Sagar Lonial, Ajai Chari, Brendan M. Weiss, Yanhong Deng, Jun Hu, Tahamtan Ahmadi, Lei Wang, Lekun Fang, Xiaojian Wu and Qiyuan Qin. Their work appears in journals such as Journal of Clinical Oncology, Blood, Oncotarget, Diseases of the Colon & Rectum and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.